BSP implementation of European S3 - level evidence-based treatment guidelines for stage I-III periodontitis in UK clinical practice

West, Nicola; Chapple, Iain L. C.; Claydon, Nicholas; D’Aiuto, Francesco; Donos, Nikos; Ide, Mark; Needleman, Ian; Kebschull, Moritz

doi:10.1016/j.jdent.2020.103562

Cited by 51 publications

(42 citation statements)

References 106 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Through repeated application of the classification, we found a significant number of patients exhibited BOP of less than 10%, alongside persistent deeper pockets of >5 mm. Following discussion, patients may decide to accept this management strategy -remaining in Step 2 of the S3 Treatment Guidelines for Periodontitis 7 rather than pursue advanced periodontal therapy such as surgical interventions (Step 3). 'This less invasive and more cost-effective approach is supported by evidence which suggests deeper pockets remain stable when patients are placed on a supportive periodontal care programme.…”

Section: Resultsmentioning

confidence: 99%

BSP implementation of the 2017 classification of periodontal diseases: a practice retrospective

et al. 2022

Self Cite

View full text Add to dashboard Cite

Introduction The new world classification of periodontal diseases and conditions was developed in 2017. The British Society of Periodontology and Implant Dentistry (BSP) implemented the classification in a series of papers published in the British Dental Journal in January 2019.Aims and objectives This study aimed to investigate if the BSP implementation was workable in general dental practice and to reveal if any lessons were learnt from its regular use two years following its release.Materials and methods This was a cross-sectional, retrospective, non-intervention analysis of a patient population (n = 891) drawn from a complete list of a private dental surgeon. Diagnostic and demographic data were drawn from the patient records, collated and analysed using SPSS Statistics v26.Results Diagnoses derived from the new classification were identified for 92% of subjects, indicating a high level of implementation. In total, 20.9% of subjects were diagnosed with periodontitis, and of these, 57% were unstable, 39% stable and 4% in remission. The mean bleeding on probing score across the cohort was 7.7%. Moreover, 76% of the non-periodontitis patients were diagnosed with 'clinical gingival health', 23% with localised gingivitis and 1% with generalised gingivitis.Conclusion The new classification has been found to be readily implemented in a general practice setting. Use of the new classification allows for close monitoring of periodontal status, and as a result, close monitoring of the effectiveness of pathways of care.

show abstract

Section: Resultsmentioning

confidence: 99%

BSP implementation of the 2017 classification of periodontal diseases: a practice retrospective

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…While the concept of antisepsis pioneered by Louis Pasteur and Robert Koch certainly laid the foundation for the control of infectious diseases and saved the lives of millions of people, it narrowed the focus of scientific efforts for many decades mainly to the exploration of bacterial pathogens, which in a healthy host are either absent or forming only a minute portion of the resident microbiota. This is particularly true in clinical dentistry, where the significance of the oral microbiota still is mostly reduced to being a health threat, exemplified by the fact, that therapeutic concepts based on the indiscriminate elimination of oral bacterial biofilms continue to dominate even the most recent evidence-based guidelines for the management of caries and periodontal disease (5)(6)(7).…”

Section: The Human Microbiomementioning

confidence: 99%

Probiotics in the Management of Gingivitis and Periodontitis. A Review

Schlagenhauf

Jockel‐Schneider

2021

Front. Dent. Med

View full text Add to dashboard Cite

In the management of intestinal health problems, the targeted use of probiotic microorganisms is a common therapeutic measure with a long-standing tradition. In clinical dentistry however, probiotics-based therapy is still a rather new and developing field, whose usefulness for the control of gingivitis and periodontitis has been questioned by recent meta-analyses and systematic reviews. The purpose of the subsequent descriptive review is to provide an introduction to the concept of probiotic microorganisms and their multifaceted health-promoting interactions with the human host and microbial competitors, followed by a detailed comparison of the results of available controlled clinical trials assessing the use of probiotics in the control of gingival and periodontal inflammations. It aims at contributing to a deeper understanding of the unique capabilities of probiotics to resolve chronic plaque-induced inflammation even in the absence of mechanical plaque control and will discuss how possible misconceptions about the rationale for using probiotics may have led to the present controversies about their usefulness as a therapeutic option.

show abstract

“…I continue to learn about the power of excellent communication, support, empathy, respect and patience. I have learnt 3,4 how these features, alongside a wealth of experience, including from members outside of our profession, contributes to our overall knowledge and ability to lead, and to understand others as well as provide viable solutions.…”

Section: Joining the Dotsmentioning

confidence: 99%